Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+ 
Qantas Shares Climb as Long-Haul Pilot Deal Eases Strike Concerns 
Airbnb Stock Jumps After Q2 Earnings Beat, Strong 2026 Outlook 
Sony, TSMC Eye $6.3 Billion Japan Chip Venture for Next-Gen Image Sensors 
Cloudflare Stock Jumps 15% as Earnings Beat Estimates, 2026 Outlook Raised 
DeepSeek to Raise AI API Prices as Demand for New Models Surges 
Nvidia Seen Beating Q2 Targets as Vera Rubin Cycle Begins 
Delta Flight Makes Emergency Landing in Atlanta After Cockpit Fumes Reported 
Sinopec Boosts Russian ESPO Oil Purchases as Middle East Supply Tightens 
UOB Q2 Net Profit Rises 10% as Wealth Management Growth Boosts Earnings 
OpenAI Restricts Astra AI Over Cyberattack Risks 
DoorDash Q2 Revenue Jumps 36% as Orders and DashPass Growth Drive Results 
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations 
Deutsche Bank Upgrades Persimmon to Buy After Strong First-Half Results 
DBS Raises 2025 Outlook After Record Q2 Profit Driven by Wealth Management 
Western Digital Q4 Earnings Beat Estimates as FY2027 Outlook Tops Expectations 
AMP Shares Surge 13% After Strong Profit and A$150 Million Buyback 
H.B. Fuller Company (NYSE: FUL) has reportedly submitted a 285 pence-per-share cash offer to acquire Advanced Medical Solutions Group (LON: AMSU), intensifying takeover interest in the UK-based medical technology company. The proposed acquisition highlights growing consolidation in the healthcare and medical device sector during 2026.
The Minnesota-based adhesives manufacturer is currently conducting due diligence and holding discussions with Advanced Medical Solutions after making an unsolicited proposal on April 30, 2026. Under UK takeover regulations, H.B. Fuller must announce a firm intention to proceed with a formal bid or withdraw its interest by June 18, 2026.
According to reports, Goldman Sachs and Perella Weinberg Partners are advising H.B. Fuller on the potential transaction, while Ashurst LLP serves as legal counsel. Advanced Medical Solutions is being advised by Evercore Partners International and Investec Bank.
The possible acquisition comes shortly after private equity firm TA Associates ended its pursuit of Advanced Medical Solutions earlier this month. TA Associates had reportedly considered an offer near 280 pence per share, valuing the company at around £600 million. Before that, Montagu Private Equity also explored a potential bid but did not move forward.
Analysts believe Advanced Medical Solutions has become increasingly attractive following its 2024 acquisition of Peters Surgical, a France-based surgical products company. The deal significantly expanded AMSU’s manufacturing and sales capabilities across Europe and Asia.
The integration of Peters Surgical helped boost Advanced Medical Solutions’ 2025 revenue by 29% to £228.9 million, while adjusted EBITDA climbed 24% to £49.9 million. Industry experts suggest these stronger financial results and potential cost synergies could motivate strategic buyers like H.B. Fuller to pursue a takeover.
Despite ongoing negotiations, both companies emphasized that there is no certainty a final agreement will be reached. Investors continue monitoring developments closely as the June deadline approaches.
